Additional Benefit Seen for Colonoscopy Versus Sigmoidoscopy
By Elana Gotkine HealthDay Reporter
TUESDAY, March 5, 2024 -- There may be a limited additional colorectal cancer (CRC) screening benefit for colonoscopy compared with sigmoidoscopy, according to a study published online Feb. 29 in JAMA Network Open.
Frederik E. Juul, M.D., Ph.D., from the University of Oslo in Norway, and colleagues estimated the additional screening benefit of colonoscopy compared with sigmoidoscopy in a comparative effectiveness simulation study using pooled data for 358,204 men and women. Participants were randomly assigned to sigmoidoscopy screening or usual care.
The researchers found that colonoscopy prevented an estimated 50 CRC cases per 100,000 person-years, corresponding to a 30 percent incidence reduction, and prevented an estimated 15 CRC deaths per 100,000 person-years, corresponding to a 32 percent mortality reduction (rate ratios, 0.70 and 0.68, respectively). Compared with sigmoidoscopy, the additional benefit of colonoscopy screening was 12 fewer CRC cases and four fewer CRC deaths per 100,000 person-years, corresponding to reductions of 6.9 and 7.6 percentage points for CRC incidence and mortality. To prevent one CRC case and one CRC death, the number needed to switch from sigmoidoscopy to colonoscopy screening was 560 and 1,611, respectively.
"Compared with sigmoidoscopy screening, colonoscopy screening provided 6.9 percentage points additional reductions in CRC incidence and 7.6 percentage points additional reductions in CRC mortality, which means that the additional preventive effect of colonoscopy compared with sigmoidoscopy was less than what was achieved by introducing sigmoidoscopy screening where no screening existed," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Survival Gains Seen With Assignment to Experimental Group in Cancer Trials
TUESDAY, April 30, 2024 -- For patients with solid tumors, assignment to an experimental group in trials of investigational drugs yields significant survival gains, according to a...
Variation ID'd in Risk for Second Primary Cancer After Breast Cancer
TUESDAY, April 30, 2024 -- The risk for second primary cancer (SPC) after breast cancer (BC) varies with gender, age, and socioeconomic status, according to a study published...
People With Opioid Use Disorder Less Likely to Receive Palliative Care
MONDAY, April 29, 2024 -- People with opioid use disorder (OUD) are less likely to receive palliative care during the last 90 days before death, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.